Armando Anido
Chairman of the Board & CEO
Zynerba Pharmaceuticals

Michael Bozik, M.D.
President & CEO
Knopp Biosciences LLC

Erin Brubaker
Strategic Advisor

Christopher Burns, Ph.D.
President & CEO
Venatorx Pharmaceuticals, Inc.

Rachael Bushey
Partner and Chair of the Health Sciences Department
Pepper Hamilton LLP

Neil Campbell
Executive Chairman
Mosaigen, LLC

Christopher Cashman
Chairman
MBF Therapeutics

Susan Dillon, Ph.D.
President & CEO
Aro Biotherapeutics

Brian Doerner
Partner
Ballard Spahr LLP

Jason Frederick
Partner, Strategic Growth Markets
Ernst & Young LLP

Matthew Gantz
Chief Executive Officer
OxThera

Maxine Gowen, Ph.D.
Director & CEO
TamuroBio Inc.

Andrew Greenspan, M.D.
VP, Immunology Medical Affairs
Janssen Scientific Affairs, LLC

Brian K. Halak, Ph.D.
Partner
Domain Associates

Thomas Hess, CPA (Treasurer)
Senior Vice President & CFO
Genomind

John Hubbard, Ph.D., FCP
Healthcare Strategic Advisory Board Member
Genstar Capital

Stephen Jannetta
Partner
Morgan, Lewis & Bockius LLP

Liam Kelly
President & CEO
Teleflex Incorporated

Joseph La Barge
Chief Legal Officer
Spark Therapeutics, Inc.

Mahmood Ladha
President & Head of Dova
Dova Pharmaceuticals

David H. Ledbetter, Ph.D., FACMG
Executive Vice President & Chief Scientific Officer
Geisinger

Bryant Lim
SVP, General Counsel & Secretary
Idera Pharmaceuticals

Christian Manders
Chief Operating Officer
Promethean LifeSciences

Peter Miller
Chief Executive Officer
Optinose

Christopher Molineaux (President)
President & CEO
Life Sciences Pennsylvania

Rita Norton
Sr. VP Government Affairs & Public Policy
AmerisourceBergen Corporation

Adele C. Oliva
Co-Founder
1315 Capital

David Payne, Ph.D. DSc
Vice President, Medicine Opportunities Research
GlaxoSmithKline

Robert Radie
Independent Director

Julian Ritchey
US Head Vaccine Public Affairs and Advocacy
Sanofi Pasteur

Kathleen Shay (Secretary)
Partner
Duane Morris LLP

Bruce Shook
President & Chief Executive Officer
Intact Vascular, Inc.

Robert Smith
Sr. Vice President, Global Gene Therapy Business, Rare Disease, Pfizer Innovation Health
Pfizer Inc.

Jennifer Strong
Partner
KPMG LLP

John Swartley, Ph.D., MBA
Associate Vice Provost for Research & Managing Director, Penn Center for Innovation
University of Pennsylvania

Terri Lee Taylor (Chairman)
Vice President, State Government Affairs & Policy
Merck & Co, Inc.

Paul Testa
EVP-Operations/Supply Chain
Kyowa Kirin

Eric Teutsch
Board of Directors and Senior Commercial Advisor
Cambridge Orthopaedic Labs

Stephen Tullman (Vice-Chairman)
Managing Partner
NeXeption

Neal Walker, D.O.
President & CEO
Aclaris Therapeutics

Monte Wiltse
President & CEO
Fujirebio Diagnostics

Bryan Wolf, M.D., Ph.D.
Executive Vice President & Chief Scientific Officer
Children’s Hospital of Philadelphia

Jing Yang, Ph.D.
Lead, Pan Asian Network People and Business Resource Group
Bristol-Myers Squibb

Stephen Yoder, M.D., MBA
Executive Director, Hematology & Cell Therapy Search & Evaluation
Bristol-Myers Squibb Company